Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-12-01T01:19:15.630Z Has data issue: false hasContentIssue false
  • English
  • Français

The case for a population standardized infection ratio (SIR): A metric that marries the device SIR to the standardized utilization ratio (SUR)

Published online by Cambridge University Press:  24 June 2019

Mohamad G. Fakih Open the ORCID record for Mohamad G. Fakih [Opens in a new window] ,
Ren-Huai Huang ,
Angelo Bufalino ,
Thomas Erlinger ,
Lisa Sturm ,
Ann Hendrich  and
Ziad Haydar
Mohamad G. Fakih*
Affiliation:
Care Excellence, Ascension Healthcare, St Louis, Missouri Wayne State University School of Medicine, Detroit, Michigan
Ren-Huai Huang
Affiliation:
Ascension Clinical Research Institute, St Louis, Missouri
Angelo Bufalino
Affiliation:
Ascension Clinical Research Institute, St Louis, Missouri
Thomas Erlinger
Affiliation:
Ascension Clinical Research Institute, St Louis, Missouri
Lisa Sturm
Affiliation:
Care Excellence, Ascension Healthcare, St Louis, Missouri
Ann Hendrich
Affiliation:
Care Excellence, Ascension Healthcare, St Louis, Missouri
Ziad Haydar
Affiliation:
Care Excellence, Ascension Healthcare, St Louis, Missouri
*
Author for correspondence: Mohamad G. Fakih, MD, MPH, Care Excellence, Ascension Healthcare, 4600 Edmundson Rd, St Louis, MO 63134. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

The device standardized infection ratio (SIR) is used to compare unit and hospital performance for different publicly reported infections. Interventions to reduce unnecessary device use may select a higher-risk population, leading to a paradoxical increase in SIR for some high-performing facilities. The standardized utilization ratio (SUR) adjusts for device use for different units and facilities.

Methods:

We calculated the device SIR (calculated based on actual device days) and population SIR (defined as Σ observed events divided by Σ predicted events based on predicted device days), adjusting for the facility SUR for both central-line–associated bloodstream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs) in 84 hospitals from a single system for calendar years 2016 and 2017.

Results:

The central-line SUR was 1.02 for 801,172 central-line days, with a device SIR of 0.76 and a population SIR of 0.78, a 1.6% relative increase. On the other hand, the urinary catheter SUR was 0.90 for 757,504 urinary catheter days, with a device SIR of 0.84 and a population SIR of 0.76, a 10.0% relative decrease. The cumulative attributable difference for CAUTI to a target SIR of 1 was −135.4 for the device SIR compared to −203.66 for the population SIR, a 50.8% increase in prevented events.

Conclusion:

Population SIR accounts for predicted device utilization; thus, it is an attractive metric with which to address overall risk of infection or harm to a patient population. It also reduces the risk of selection bias that may impact the device SIR with interventions to reduce device use.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 9 , September 2019 , pp. 979 - 982
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. The study was presented in part as abstract 2158 at ID Week 2018 on October 6, 2018, in San Francisco, California.

References

Hospital-acquired conditions. Centers for Medicare and Medicaid Services website. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalAcqCond/Hospital-Acquired_Conditions.html. Accessed February 9, 2019.Google Scholar
The NHSN Standardized Infection Ratio (SIR): a guide to the SIR. Centers for Disease Control and Prevention. https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/nhsn-sir-guide.pdf. Accessed February 9, 2019.Google Scholar
Fakih, MG, Greene, MT, Kennedy, EH, et al. Introducing a population-based outcome measure to evaluate the effect of interventions to reduce catheter-associated urinary tract infection. Am J Infect Control 2012;40:359–364.CrossRefGoogle ScholarPubMed
The NHSN Standardized Utilization Ratio (SUR): a guide to the SUR. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/nhsn-sur-guide-508.pdf. Accessed February 9, 2019.Google Scholar
Wright, M-O, Kharasch, M, Beaumont, JL, Peterson, LR, Robicsek, A. Reporting catheter-associated urinary tract infections: denominator matters. Infect Control Hosp Epidemiol 2011;32:635–640.CrossRefGoogle ScholarPubMed
Soe, MM, Gould, CV, Pollock, D, Edwards, J. Targeted assessment for prevention of healthcare-associated infections: a new prioritization metric. Infect Control Hosp Epidemiol 2015;36:1379–1384.CrossRefGoogle ScholarPubMed
Cawcutt, KA, Hankins, RJ, Micheels, TA, Rupp, ME. Optimizing vascular-access device decision-making in the era of midline catheters. Infect Control Hosp Epidemiol 2019;40:674–680.Google ScholarPubMed
Saint, S, Greene, MT, Krein, SL, et al. A program to prevent catheter-associated urinary tract infection in acute care. N Engl J Med 2016;374:2111–2119.CrossRefGoogle ScholarPubMed
Advani, SD, Fakih, MG. The evolution of catheter-associated urinary tract infection (CAUTI): is it time for more inclusive metrics?. Infect Control Hosp Epidemiol 2019;40:681–685.CrossRefGoogle ScholarPubMed
Chopra, V, Flanders, SA, Saint, S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med 2015;163(6 suppl):S1–S40.CrossRefGoogle ScholarPubMed
Gray, M, Skinner, C, Kaler, W. External collection devices as an alternative to the indwelling urinary catheter: evidence-based review and expert clinical panel deliberations. J Wound Ostomy Continence Nurs 2016;43:301–307.CrossRefGoogle ScholarPubMed
Meddings, J, Rogers, MA, Krein, SL, Fakih, MG, Olmsted, RN, Saint, S. Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review. BMJ Qual Saf 2014;23:277–289.CrossRefGoogle ScholarPubMed
Fakih, MG, Gould, CV, Trautner, BW, et al. Beyond infection: device utilization ratio as a performance measure for urinary catheter harm. Infect Control Hosp Epidemiol 2016;37:327–333.CrossRefGoogle ScholarPubMed
Jackson, SS, Leekha, S, Magder, LS, et al. The effect of adding comorbidities to current centers for disease control and prevention central-line–associated bloodstream infection risk-adjustment methodology. Infect Control Hosp Epidemiol 2017;38:1019–1024.CrossRefGoogle ScholarPubMed